关注
Tanmay Kulkarni
标题
引用次数
引用次数
年份
A year-long extended release nanoformulated cabotegravir prodrug
TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ...
Nature materials 19 (8), 910-920, 2020
842020
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
N Gautam, JEM McMillan, D Kumar, AN Bade, Q Pan, TA Kulkarni, W Li, ...
Nature communications 12 (1), 3453, 2021
382021
A fully integrated online platform for real time monitoring of multiple product quality attributes in biopharmaceutical processes for monoclonal antibody therapeutics
Y Liu, C Zhang, J Chen, J Fernandez, P Vellala, TA Kulkarni, I Aguilar, ...
Journal of Pharmaceutical Sciences 111 (2), 358-367, 2022
372022
Non-viral vectors for delivery of nucleic acid therapies for cancer
S Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A Dasgupta
BioTech 11 (1), 6, 2022
212022
The immunopathobiology of SARS-CoV-2 infection
M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ...
FEMS Microbiology Reviews 45 (6), fuab035, 2021
162021
Non-viral gene therapy vectors for cancer treatment
S Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A Dasgupta
Preprints, 2022
12022
Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis
S Kanvinde, S Deodhar, TA Kulkarni, CM Jogdeo
BioTech 12 (2), 34, 2023
2023
Development of Once-A-Year Injectable Formulation of Cabotegravir for Prevention and Treatment of HIV Infection
TA Kulkarni
2021
Development, Formulation and Evaluation of 5 Fluorouracil Tablet as a Viable Colon Targeted Drug Delivery System using Compression Coat of Polymer (s)
MP Bhandarwad, SS Deodhar, TA Kulkarni, TA Shaikh, AD Savkare
系统目前无法执行此操作,请稍后再试。
文章 1–9